Evercore ISI Group analyst Umer Raffat initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Outperform rating.
Obesity And Diabetes Drugs Demand Help Distributor Cencora Propel Revenue In Q3
Cencora Inc's (NYSE: COR), formerly AmerisourceBergen Corporation,